Asahi Kasei

Summary

Asahi Kasei appeared to be the Corporate Investor, which was created in 1931. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Clinical Trials. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Atox Bio, Artisan Pharma, Arcterus.

The high activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 25 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Asahi Kasei works on 20 percentage points less the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Asahi Kasei, startups are often financed by New Leaf Venture Partners, Tribeca Venture Partners, Pritzker Group Venture Capital. The meaningful sponsors for the fund in investment in the same round are Z-kai, Yuval Tal, Tribeca Venture Partners. In the next rounds fund is usually obtained by General Motors Ventures, Z-kai, Vincent Deltrieu.